In today’s episode host Ginger Vieira discusses the latest advancements and emerging trends in long-acting insulin therapy with guest Lucia M. Novak, MSN, ANP-BC, BC-ADM.
They cover:
The latest clinical trials and guidelines
New insulin formations
Smart delivery technologies
The potential of GLP-1 and GIP hormones
Advice on lowering treatment burden and improving the quality of life for those living with diabetes
Lucia is a board-certified Nurse Practitioner with almost 30 years of clinical expertise in diabetes management. She’s a Consultant, Advisor, National Speaker, Author, Educator, Advocate, and is the President and Founder of Diabesity, LLC.
If you’d like to deepen your knowledge on this topic, why not enroll in the e-Learning course ‘Updates and Emerging Trends in Long-Acting Insulin Therapy’ on the Unlok Education website. Led by esteemed experts Dr. Arthi Thirumalai and Prof. Dr. Eda Cengiz, this session delves into recent clinical trials, updated guidelines, and emerging trends that are shaping the future of diabetes management.
This is an accredited activity that gives you 1 CME/CPD credit.
Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.
In today’s episode, host Ginger Vieria is joined by Dr. Egils Bogdanovics to hear perspectives on how to effectively combine long-acting insulin with other diabetes treatments.
They discuss combining long-acting insulin with mealtime insulin, oral medications, and GLP-1 receptor agonists, the role of lifestyle modifications in optimizing insulin effectiveness, and the use of CGM data to refine insulin therapy.
Dr. Egils Bogdanovics is an Assistant Clinical Professor of Medicine at the University of Connecticut. He’s Medical Director at the Charlotte Hungerford Hospital Diabetes Center, and a diplomate of the American Board of Internal Medicine Endocrinology, Diabetes, and Metabolism.
Visit the Insulin Knowledge Hub on the ATTD Education Portal for further resources and in-depth content on long-acting insulin therapy.
Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.
In today’s episode, host Ginger Vieria is joined by Aimée José, RD, CDCES to discuss factors for consideration when initiating, titrating, and monitoring long-acting insulin.
Their conversation provides you with step-by-step guidance on dose titration and adjustments, monitoring and managing adverse effects, and strategies for patient education and engagement during initiation. Aimée draws from her clinical experience working with patients in a non-judgemental manner, encouraging better collaboration between patient and provider.
Aimée José is Principal Clinical Educator at Codex Health. She’s a highly skilled Diabetes Educator with expertise in clinical diabetes care & technology.
Visit the Insulin Knowledge Hub on the Unlok Education website for further resources and in-depth content on long-acting insulin therapy.
Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.
In today’s episode, host Ginger Vieria is joined by pediatric endocrinologist Dr. Ladan Davallow to discuss the factors influencing patient selection.
They explore factors including insulin resistance, lifestyle considerations, and treatment goals, and draw from real-world examples of how clinicians decide on the best candidates for long-acting insulin therapy.
Ladan Davallow, MD is a Pediatric Endocrinologist and Childhood Type 1 Diabetes Consultant & Certified Coach.
She is based in the Medical University of South Carolina Children’s Health Hospital, and is the Co-Founder of and Pediatric Endocrinologist at EndoMD Health, a Virtual Pediatric Endocrine Care Practice.
If you'd like to dive deeper into today’s topic, don’t miss our workshop video: “Patient Selection and Initiation of Long-Acting Insulin Therapy” on the ATTD Education Portal, where Dr. Rodolfo Galindo, Dr. Amit Gupta, Dr. Medha Munshi, Prof. Concetta Irace, and Prof. Raffaella Buzzetti explore two real-world case studies and share expert strategies to guide clinical decisions.
Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.
In today’s episode Ginger Vieria is joined by Diana Isaacs, PharmD, and Endocrine Clinical Pharmacist, to dive deeper into the pharmacokinetics and pharmacodynamics of long-acting insulin.
They explore how long-acting insulin can improve blood glucose levels, reduce the burden of daily injections, and simplify insulin management for the person with diabetes.
Diana Isaacs is a diabetes advocate and speaker. She’s a Director in Education & Training in Diabetes Technology at the Cleveland Clinic, and she’s also a Fellow of the Association of Diabetes Care and Education Specialists (FADCES) and the American College of Clinical Pharmacy (FCCP).
If you’d like to dive deeper into today’s topic, don’t miss our CME/CPD accredited e-learning course, titled Breaking New Ground: Once-Weekly Insulin.
The session delves into the evolution of long-acting insulin therapy and introduces groundbreaking once-weekly formulations. 1 CME/CPD Credit available.
Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.
In the first episode of ATTD’s brand new series on long-acting insulin, join our host Ginger Vieira and guest Jennifer Okemah, RD, CDCES, as they provide an overview of the role of long-acting insulin in diabetes management, the potential benefits, and the evolution of the different formulations available today.
Jennifer Okemah has been a Registered Dietitian (RD)/Nutritionist since 2005 and a Certified Diabetes Care and Education Specialist (CDCES) since 2007.
She has an additional certification as a Sports Specialist in Dietetics as well as being Board Certified in Advanced Diabetes Management.
Explore more on the ATTD Education Portal. Register now to access exclusive content and stay ahead in the field!
Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.
What’s next in long-acting insulin therapy? Find out in ATTD Diabetes Talks: Long-Acting Insulin Uncovered, a new podcast for healthcare professionals who want to stay ahead in diabetes care.
Hosted by Ginger Vieira and powered by ATTD, this series brings you real conversations with CDCESs, PharmDs, pediatric endocrinologists, and people living with diabetes.
We’ll dive into the latest trends, explore clinical benefits, discuss patient selection strategies, and share real-world success stories to help you apply new insights in your practice.
Subscribe now and join us as we uncover how long-acting insulin is shaping the future of diabetes management.
In this episode of ATTD 2025 Conference Catch-Up, we dive into Toward the Cure of Type 1 Diabetes, featuring exciting discussions on cutting-edge strategies, from gene therapy to biomaterials, aimed at advancing beta cell replacement and ultimately finding a cure for type 1 diabetes.
Join us as we summarize key takeaways from these thought-provoking presentations:
This episode is an essential listen for endocrinologists, diabetes researchers, clinicians, and healthcare professionals interested in the latest advances in curative therapies, including gene therapy, biomaterials, and novel treatments aimed at reversing type 1 diabetes.
Enjoy the listen!
This podcast was created using AI to provide a quick and insightful summary of an ATTD 2025 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information.
ATTD 2025, the 18th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on March 19-22, 2025, in Amsterdam.
In this episode of ATTD 2025 Conference Catch-Up, we dive into View, Counterview: Time in Tight Range Should Be the Primary Treatment Goals and Outcome Measure in Diabetes, featuring a lively debate on the role of time in tight range as a primary treatment goal, weighing the benefits of advanced CGM technology against the potential psychological and practical challenges.
Join us as we summarize key takeaways from these thought-provoking presentations:
This episode is an essential listen for endocrinologists, diabetes specialists, and healthcare professionals looking to explore the role of tight glycemic control in diabetes management, understand the advantages and challenges of using time in range as an outcome measure, and gain insight into the evolving landscape of diabetes care.
Enjoy the listen!
This podcast was created using AI to provide a quick and insightful summary of an ATTD 2025 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information.
ATTD 2025, the 18th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on March 19-22, 2025, in Amsterdam.
In this episode of ATTD 2025 Conference Catch-Up, we dive into Debate: Is There a Real Unmet Need for Continuous Ketone Monitoring?, featuring a compelling discussion on the potential benefits and challenges of continuous ketone monitoring, exploring its role in preventing diabetic ketoacidosis and its place in diabetes management.
Join us as we summarize key takeaways from these thought-provoking presentations:
This episode is an essential listen for endocrinologists, diabetes specialists, and healthcare professionals looking to understand the potential clinical impact of continuous ketone monitoring in diabetes management, its role in preventing complications, and its future integration into patient care.
Enjoy the listen!
This podcast was created using AI to provide a quick and insightful summary of an ATTD 2025 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information.
ATTD 2025, the 18th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on March 19-22, 2025, in Amsterdam.
In this episode of ATTD 2025 Conference Catch-Up, we dive into AI-Driven Healthcare: Opportunities and Challenges, featuring discussions on the transformative potential of AI in diabetes and hypertension management, along with the challenges of integrating machine learning into clinical practice while ensuring patient safety and regulatory compliance.
Join us as we summarize key takeaways from these thought-provoking presentations:
This episode is an essential listen for endocrinologists, diabetes specialists, data scientists, and healthcare professionals looking to explore the latest advancements in AI and machine learning technologies, and how they are shaping the future of personalized healthcare, diabetes management, and diagnostic accuracy.
Enjoy the listen!
This podcast was created using AI to provide a quick and insightful summary of an ATTD 2025 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information.
ATTD 2025, the 18th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on March 19-22, 2025, in Amsterdam.https://attd.kenes.com
In this episode of ATTD 2025 Conference Catch-Up, we dive into Debate: Adaptive Trials in the Post-Teplizumab Era: To Placebo or Not to Placebo?, featuring a lively discussion on the ethics and necessity of placebo-controlled trials in type 1 diabetes research, with a focus on adaptive trial designs and the future of treatment testing.
Join us as we summarize key takeaways from these thought-provoking presentations:
This episode is an essential listen for researchers, clinicians, and diabetes specialists interested in the future of clinical trial design, the ethical considerations in testing new treatments, and the evolving landscape of type 1 diabetes research.
Enjoy the listen!
This podcast was created using AI to provide a quick and insightful summary of an ATTD 2025 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information.
ATTD 2025, the 18th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on March 19-22, 2025, in Amsterdam. https://attd.kenes.com
In this episode of ATTD 2025 Conference Catch-Up, we dive into Updates on Diabetes Management and Female Health, featuring discussions on gender-specific challenges in diabetes care, the role of technology and AI in addressing these disparities, and the need for personalized treatment approaches for women with diabetes.
Join us as we summarize key takeaways from these thought-provoking presentations:
This episode is an essential listen for endocrinologists, diabetes specialists, healthcare providers, and researchers who are looking to gain insights into the latest gender-specific approaches in diabetes management and how to leverage technology to improve patient outcomes for women with diabetes.
Enjoy the listen!
This podcast was created using AI to provide a quick and insightful summary of an ATTD 2025 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information.
ATTD 2025, the 18th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on March 19-22, 2025, in Amsterdam.https://attd.kenes.com
In this episode of ATTD 2025 Conference Catch-Up, we dive into Type 2 Diabetes: Empowering Patients with Personalized Treatment, featuring cutting-edge discussions on the role of SGLT2 inhibitors, CGM, and personalized approaches to managing type 2 diabetes and pre-diabetes, with a focus on improving patient outcomes.
Join us as we summarize key takeaways from these thought-provoking presentations:
This episode is an essential listen for endocrinologists, diabetes care specialists, healthcare providers, and researchers focusing on innovative, patient-centered approaches to managing type 2 diabetes and pre-diabetes, aimed at improving both clinical outcomes and patient experiences.
Enjoy the listen!
This podcast was created using AI to provide a quick and insightful summary of an ATTD 2025 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information.
ATTD 2025, the 18th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on March 19-22, 2025, in Amsterdam.https://attd.kenes.com
In this episode of ATTD 2025 Conference Catch-Up, we dive into Decision Support Technologies – Are They Delivering?, featuring discussions on the effectiveness of AI-driven tools in improving diabetes management, enhancing patient autonomy, and supporting healthcare providers in delivering personalized care.
Join us as we summarize key takeaways from these thought-provoking presentations:
This episode is an essential listen for endocrinologists, diabetes specialists, AI innovators, and healthcare providers looking to explore the evolving role of decision support technologies in improving diabetes care, patient outcomes, and clinical efficiency.
Enjoy the listen!
This podcast was created using AI to provide a quick and insightful summary of an ATTD 2025 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information.
ATTD 2025, the 18th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on March 19-22, 2025, in Amsterdam.https://attd.kenes.com
ATTD 2025, the 18thInternational Conference on Advanced Technologies & Treatments forDiabetes, is taking place on March 19-22, 2025, in Amsterdam.
In this episode of ATTD 2025 Conference Catch-Up, we dive into Fully Closed-Loop: A New Era of Control, featuring cutting-edge advancements in machine learning–driveninsulin delivery systems and their potential to transform diabetes management across everyday life, exercise, meals, and clinical settings.
Join us as we summarize key takeaways from these thought-provoking presentations:
This episode is an essential listen for endocrinologists, diabetes specialists, clinicians, and healthcare professionals involved in insulin therapy, looking to stay at the forefront of automated systems and machine learning technologies that are reshaping the future of diabetes management.
Enjoy the listen!
This podcast was created using AI to provide a quick and insightful summary of an ATTD 2025 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information.
ATTD 2025, the 18th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on March 19-22, 2025, in Amsterdam.https://attd.kenes.com
In this episode of ATTD 2025 Conference Catch-Up, we dive into Use of Technology in Pregnancy, featuring innovative discussions on the challenges of managing diabetes during pregnancy, the impact of hybrid closed-loop and insulin delivery systems on glycemic control, and the need for individualized care to optimize outcomes for both mothers and babies.
Join us as we summarize key takeaways from these thought-provoking presentations:
This episode is an essential listen for obstetricians, endocrinologists, diabetes specialists, and healthcare professionals involved in managing pregnant women with diabetes. Learn about the latest advances in diabetes technology and how to apply them for optimal outcomes during pregnancy.
Enjoy the listen!
This podcast was created using AI to provide a quick and insightful summary of ATTD 2025 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information.
ATTD 2025, the 18th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on March 19-22, 2025, in Amsterdam. https://attd.kenes.com
In this episode of ATTD 2025 Conference Catch-Up, we dive into Time in Tight Glycemic Range: A Crucial Goal or an Unnecessary Burden?, featuring an in-depth exploration of the complexities behind glycemic control, the challenges of achieving tight ranges, and the need for personalized, accessible diabetes management strategies.
Join us as we summarize key takeaways from these thought-provoking presentations:
This episode is an essential listen for endocrinologists, diabetes specialists, healthcare providers, and researchers looking to understand the physiological, social, and practical complexities of achieving tight glycemic control and how to better support personalized diabetes management.
Enjoy the listen!
This podcast was created using AI to provide a quick and insightful summary of ATTD 2025 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information.
ATTD 2025, the 18th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on March 19-22, 2025, in Amsterdam. https://attd.kenes.com
In this episode of ATTD 2025 Conference Catch-Up, we dive into Closed-Loop Control Systems: Advancements and Applications, featuring breakthrough discussions on the latest closed-loop systems, their impact on glycemic control, and the ongoing advancements aimed at improving accessibility and outcomes for individuals with type 1 diabetes.
Join us as we summarize key takeaways from these thought-provoking presentations:
This episode is an essential listen for healthcare professionals and researchers in the field of diabetes care, looking to stay updated on the latest advancements in closed-loop insulin delivery systems, as well as their future potential for improving glycemic control and quality of life for patients with type 1 diabetes.
Enjoy the listen!
This podcast was created using AI to provide a quick and insightful summary of ATTD 2025 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information.
ATTD 2025, the 18th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on March 19-22, 2025, in Amsterdam. https://attd.kenes.com
In this episode of ATTD 2025 Conference Catch-Up, we dive into the ATTD Yearbook Session, featuring a dynamic review of the year’s most impactful advances in diabetes technology, therapies, and care delivery—from AI-driven insulin systems to digital health, telemedicine, and emerging treatments across all ages and care settings.
Join us as we summarize key takeaways from these thought-provoking presentations:
This episode is an essential listen for diabetes clinicians, researchers, digital health innovators, and healthcare leaders looking to stay informed on the biggest developments of the past year in diabetes care—across clinical practice, digital transformation, and therapeutic innovation.
Enjoy the listen!
This podcast was created using AI to provide a quick and insightful summary of ATTD 2025 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information.
ATTD 2025, the 18th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on March 19-22, 2025, in Amsterdam. https://attd.kenes.com
